MENU

AGMB Agomab Therapeutics NV Forecast, Technical & Fundamental Analysis

AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need... Show more

Interact to see
Advertisement
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NUDM40.161.17
+3.00%
Nuveen ESG International Developed Markets Equity ETF (NUDM)
DBEZ62.561.54
+2.52%
Xtrackers MSCI Eurozone Hedged Equity ETF (DBEZ)
VBR249.264.26
+1.74%
Vanguard Morningstar Small-Cap Value ETF (VBR)
PRFD49.200.14
+0.29%
PIMCO Preferred and Capital Securities Active ETF (PRFD)
FARX29.28-0.26
-0.87%
Frontier Asset Absolute Return ETF
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
1/6 Posthoflei
Phone
+32 33189170
Employees
80
Web
https://www.agomab.com
Agomab Therapeutics (AGMB) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com